XML 61 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Debt and Other Contractual Obligations - Additional Information (Detail)
1 Months Ended 12 Months Ended
May 31, 2017
Facility
Mar. 31, 2017
USD ($)
Jan. 31, 2017
USD ($)
Sep. 30, 2013
USD ($)
Dec. 31, 2017
USD ($)
Facility
Loan
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Debt Instrument [Line Items]              
Amount owe under loan facility         $ 2,422,000    
Lease agreement term         39 months    
Lease agreement, expiration year         2019    
Lease agreement rent free period         3 months    
Capital lease term         60 months    
Proceeds from equipment loans         $ 1,501,000    
Rent Expense         400,000 $ 400,000 $ 300,000
Interest expense, net         $ 100,000 100,000 100,000
Loan for Equipment [Member] | Nottingham, UK Facility [Member]              
Debt Instrument [Line Items]              
Number of loans | Loan         2    
Loans payment maturity month and year         2022-03    
Loan for Equipment [Member] | Loan One [Member] | Nottingham, UK Facility [Member]              
Debt Instrument [Line Items]              
Proceeds from equipment loans     $ 900,000        
Interest rates at the end of period         2.09%    
Loan for Equipment [Member] | Loan Two [Member] | Nottingham, UK Facility [Member]              
Debt Instrument [Line Items]              
Proceeds from equipment loans   $ 600,000          
Interest rates at the end of period         2.09%    
Juniper Pharma Services [Member]              
Debt Instrument [Line Items]              
Debt assumed       $ 3,900,000      
Number of loan facilities | Facility         3    
Number of loan facilities repaid | Facility 1            
Gain loss on refinancing of debt         $ 0    
Amount owe under loan facility         $ 2,400,000    
Weighted average interest rate for the period         2.76%    
Juniper Pharma Services [Member] | Regional Growth Fund [Member]              
Debt Instrument [Line Items]              
Debt assumed       $ 2,500,000 $ 2,500,000    
Obligation under a grant arrangement, maturity date       Oct. 01, 2017      
Other income         $ 600,000 $ 700,000 $ 500,000
Term of agreement over which income was recognized         3 years    
Juniper Pharma Services [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Loan facilities repayment period         7 years    
Juniper Pharma Services [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Loan facilities repayment period         15 years    
Juniper Pharma Services [Member] | Loan Facility One [Member]              
Debt Instrument [Line Items]              
Loan repayment commencement period         2013-02    
Loan facilities bear interest rate         1.95%    
Loan facility interest rate description         base rate plus 1.95%    
Weighted average interest rate at the end of period         2.45%    
Juniper Pharma Services [Member] | Loan Facility Two [Member]              
Debt Instrument [Line Items]              
Loan repayment commencement period         2013-10    
Loan facilities bear interest rate         2.55%    
Loan facility interest rate description         base rate plus 2.55%    
Weighted average interest rate at the end of period         3.05%    
Juniper Pharma Services [Member] | Loan Facility Three [Member]              
Debt Instrument [Line Items]              
Loan repayment commencement period         2013-10    
Loan facilities bear interest rate         2.99%